Drug Treatment of the Cognitive, Emotional, and Behavioral Symptoms of Alzheimer's Disease This work was supported by a grant from the National Institute on Aging/National Institutes of Health (1-P30-AG12300) from the Alzheimer’s Disease Center. Drugs are employed to treat the cognitive, emotional, and behavioral symptoms of Alzheimer’s disease (AD) and other dementias. Some drugs have been found useful empirically, while the use ... Article
Article  |   December 01, 1997
Drug Treatment of the Cognitive, Emotional, and Behavioral Symptoms of Alzheimer's Disease
Author Affiliations & Notes
  • Myron F. Weiner
    Department of Psychiatry and Neurology University of Texas Southwestern Medical Center, Dallas
Article Information
Articles
Article   |   December 01, 1997
Drug Treatment of the Cognitive, Emotional, and Behavioral Symptoms of Alzheimer's Disease
SIG 2 Perspectives on Neurophysiology and Neurogenic Speech and Language Disorders, December 1997, Vol. 7, 26-31. doi:10.1044/nnsld7.4.26
SIG 2 Perspectives on Neurophysiology and Neurogenic Speech and Language Disorders, December 1997, Vol. 7, 26-31. doi:10.1044/nnsld7.4.26
This work was supported by a grant from the National Institute on Aging/National Institutes of Health (1-P30-AG12300) from the Alzheimer’s Disease Center.
Drugs are employed to treat the cognitive, emotional, and behavioral symptoms of Alzheimer’s disease (AD) and other dementias. Some drugs have been found useful empirically, while the use of others has been based on our growing knowledge of the pathophysiology of AD. Drugs for ameliorating the cognitive symptoms are frequently called cognitive enhancers. Drugs for treating the emotional and behavioral symptoms are called psychotropics. Although cognitive deficits comprise the chief diagnostic criteria of dementia, emotional and behavioral symptoms occur with almost equal frequency (Colenda, 1995).
First Page Preview
First page PDF preview
First page PDF preview ×
View Large
Become a SIG Affiliate
Pay Per View
Entire SIG 2 Perspectives on Neurophysiology and Neurogenic Speech and Language Disorders content & archive
24-hour access
This Issue
24-hour access
This Article
24-hour access
We've Changed Our Publication Model...
The 19 individual SIG Perspectives publications have been relaunched as the new, all-in-one Perspectives of the ASHA Special Interest Groups.